Splenic switch-off as a novel marker for adenosine response in nitrogen-13 ammonia PET myocardial perfusion imaging: Cross-validation against CMR using a hybrid PET/MR device.
Hybrid imaging
MPI
MRI
Myocardial blood flow
PET
Vasodilators
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
28
05
2020
accepted:
09
11
2020
pubmed:
24
12
2020
medline:
7
6
2022
entrez:
23
12
2020
Statut:
ppublish
Résumé
No methodology is available to distinguish truly reduced myocardial flow reserve (MFR) in positron emission tomography myocardial perfusion imaging (PET MPI) from seemingly impaired MFR due to inadequate adenosine response. The adenosine-induced splenic switch-off (SSO) sign has been proposed as a potential marker for adequate adenosine response in cardiac magnetic resonance (CMR). We assessed the feasibility of detecting SSO in nitrogen-13 ammonia PET MPI using SSO in CMR as the standard of reference. Fifty patients underwent simultaneous CMR and PET MPI on a hybrid PET/MR device with co-injection of a gadolinium-based contrast agent and nitrogen-13 ammonia during rest and adenosine-induced stress. In CMR, SSO was assessed visually (positive vs negative SSO) and quantitatively by calculating the ratio of the peak signal intensity of the spleen during stress over rest (SIR). In PET MPI, the splenic signal activity ratio (SAR) was calculated as the maximal standard uptake value of the spleen during stress over rest. The median SIR was significantly lower in patients with positive versus negative SSO in CMR (0.57 [IQR 0.49 to 0.62] vs 0.89 [IQR 0.76 to 0.98]; P < .001). Similarly, median SAR in PET MPI was significantly lower in patients with positive versus negative SSO (0.40 [IQR 0.32 to 0.45] vs 0.80 [IQR 0.47 to 0.98]; P < .001). Similarly to CMR, SSO can be detected in nitrogen-13 ammonia PET MPI. This might help distinguish adenosine non-responders from patients with truly impaired MFR due to microvascular dysfunction or multivessel coronary artery disease.
Sections du résumé
BACKGROUND
No methodology is available to distinguish truly reduced myocardial flow reserve (MFR) in positron emission tomography myocardial perfusion imaging (PET MPI) from seemingly impaired MFR due to inadequate adenosine response. The adenosine-induced splenic switch-off (SSO) sign has been proposed as a potential marker for adequate adenosine response in cardiac magnetic resonance (CMR). We assessed the feasibility of detecting SSO in nitrogen-13 ammonia PET MPI using SSO in CMR as the standard of reference.
METHODS AND RESULTS
Fifty patients underwent simultaneous CMR and PET MPI on a hybrid PET/MR device with co-injection of a gadolinium-based contrast agent and nitrogen-13 ammonia during rest and adenosine-induced stress. In CMR, SSO was assessed visually (positive vs negative SSO) and quantitatively by calculating the ratio of the peak signal intensity of the spleen during stress over rest (SIR). In PET MPI, the splenic signal activity ratio (SAR) was calculated as the maximal standard uptake value of the spleen during stress over rest. The median SIR was significantly lower in patients with positive versus negative SSO in CMR (0.57 [IQR 0.49 to 0.62] vs 0.89 [IQR 0.76 to 0.98]; P < .001). Similarly, median SAR in PET MPI was significantly lower in patients with positive versus negative SSO (0.40 [IQR 0.32 to 0.45] vs 0.80 [IQR 0.47 to 0.98]; P < .001).
CONCLUSION
Similarly to CMR, SSO can be detected in nitrogen-13 ammonia PET MPI. This might help distinguish adenosine non-responders from patients with truly impaired MFR due to microvascular dysfunction or multivessel coronary artery disease.
Identifiants
pubmed: 33354759
doi: 10.1007/s12350-020-02448-y
pii: 10.1007/s12350-020-02448-y
pmc: PMC9163112
doi:
Substances chimiques
Nitrogen Radioisotopes
0
Nitrogen-13
0
Ammonia
7664-41-7
Adenosine
K72T3FS567
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1205-1214Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020. The Author(s).
Références
JACC Cardiovasc Imaging. 2017 May;10(5):578-581
pubmed: 28017391
Int J Cardiovasc Imaging. 2018 Apr;34(4):625-632
pubmed: 29177579
J Cardiovasc Magn Reson. 2017 Jan 13;19(1):1
pubmed: 28081721
J Am Coll Cardiol. 2005 Feb 15;45(4):553-8
pubmed: 15708703
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
J Nucl Cardiol. 2017 Dec;24(6):2064-2128
pubmed: 28916938
J Nucl Med. 1990 Dec;31(12):1899-905
pubmed: 2266384
J Cardiovasc Magn Reson. 2019 Jun 24;21(1):33
pubmed: 31230593
Radiology. 2015 Sep;276(3):732-40
pubmed: 25923223
Circulation. 2003 Apr 15;107(14):1877-83
pubmed: 12668522
J Magn Reson Imaging. 2016 Mar;43(3):566-73
pubmed: 26285057
J Nucl Cardiol. 2019 Dec;26(6):1898-1900
pubmed: 29948893
J Nucl Cardiol. 2019 Dec;26(6):1888-1897
pubmed: 29651739
J Am Coll Cardiol. 2012 Oct 30;60(18):1828-37
pubmed: 23040573
Am J Cardiol. 1997 May 15;79(10):1319-22
pubmed: 9165150
Eur Heart J Cardiovasc Imaging. 2017 Nov 01;18(11):1216-1221
pubmed: 28329392
J Nucl Cardiol. 2019 Aug;26(4):1107-1118
pubmed: 29168158
J Am Coll Cardiol. 1984 May;3(5):1205-11
pubmed: 6707370
Purinergic Signal. 2008 Sep;4(3):267-85
pubmed: 18443747
J Nucl Med. 2012 Aug;53(8):1230-4
pubmed: 22776752